Juan Stephanie, Harxhi Ante, Kaul Simrati, Woods Breeana, Tran Monica, Geonnotti Gabrielle, Gupta Archit, Dean Emily, Saunders Cassandra E, Payne Gloria
Janssen Scientific Affairs, LLC, Titusville, NJ, United States.
Johnson & Johnson Technology Services, Titusville, NJ, United States.
JMIR Cardio. 2025 Mar 17;9:e56053. doi: 10.2196/56053.
Care4Today is a digital health platform developed by Johnson & Johnson comprising a patient mobile app (Care4Today Connect), a health care provider (HCP) portal, and an educational website. It aims to improve medication adherence; enable self-reporting of health experiences; provide patient education; enhance connection with HCPs; and facilitate data and analytics learning across disease areas, including cardiovascular disease.
This study aimed to gather patient feedback on Care4Today Connect, specifically the coronary artery disease (CAD) and peripheral artery disease (PAD) module, and to cocreate and validate features with patients to optimize the app experience for those with CAD, PAD, or both.
We conducted 3 research engagements between November 2022 and May 2023. Participants were US-based adults recruited and consented through the sponsor's Patient Engagement Research Council program. Participants self-reported a diagnosis of cardiovascular disease, and in some cases, specifically, CAD, PAD, or both. Part 1, internet survey, posed quantitative questions with Likert-scale answer options about existing app features. Part 2, virtual focus group, and part 3, virtual individual interviews, both used semistructured qualitative discussion to cocreate and validate new app enhancements. The quantitative data from part 1 was evaluated descriptively to categorize mobile health app use, confidence in the ability to use the app, and motivations for app use. The qualitative discussions from parts 2 and 3 were synthesized to understand participants' app needs and preferences to inform an optimal app experience.
The response rate for part 1, internet survey, was 67% (37/55). Most participants felt at least somewhat confident using the app after seeing the newly added app tutorial (33/37, 89%), and at least somewhat confident in their ability to earn points for completing activities using app instructions (33/37, 89%). In part 2, virtual focus group (n=3), and part 3, virtual individual interviews (n=8), participants collectively preferred to enhance the app with (1) the ability to automatically add medication data for tracking and (2) the ability to receive relevant care team feedback on their self-reported health experiences. Participants would be willing to spend 10-15 minutes a day tracking 4-5 health experiences, especially those requested by their HCP.
Participants prefer apps that can reduce user burden and provide information relevant to them. Care4Today Connect can optimize the user experience for patients with CAD, PAD, or both with the automatic addition of medication data for tracking and in-app care team feedback on patient self-reported health experiences.
“今日关爱”（Care4Today）是强生公司开发的一个数字健康平台，包括一款患者移动应用程序（“今日关爱连接”[Care4Today Connect]）、一个医疗服务提供者（HCP）门户和一个教育网站。其目标是提高用药依从性；实现健康体验的自我报告；提供患者教育；加强与医疗服务提供者的联系；并促进跨疾病领域的数据和分析学习，包括心血管疾病。
本研究旨在收集患者对“今日关爱连接”的反馈，特别是冠状动脉疾病（CAD）和外周动脉疾病（PAD）模块的反馈，并与患者共同创建和验证功能，以优化CAD、PAD患者或两者兼有的患者的应用体验。
我们在2022年11月至2023年5月期间进行了3次研究活动。参与者是通过赞助商的患者参与研究委员会计划招募并获得同意的美国成年人。参与者自我报告患有心血管疾病，在某些情况下，具体为CAD、PAD或两者兼有。第1部分，互联网调查，提出了关于现有应用功能的带有李克特量表答案选项的定量问题。第2部分，虚拟焦点小组，以及第3部分，虚拟个人访谈，均使用半结构化定性讨论来共同创建和验证新的应用增强功能。对第1部分的定量数据进行描述性评估，以对移动健康应用的使用情况、使用应用的能力信心以及使用应用的动机进行分类。对第2部分和第3部分的定性讨论进行综合，以了解参与者的应用需求和偏好，为优化应用体验提供信息。
第1部分互联网调查的回复率为67%（37/55）。大多数参与者在查看新添加的应用教程后，对使用该应用至少有一定信心（33/37，89%），并且对按照应用说明完成活动赚取积分的能力至少有一定信心（33/37，89%）。在第2部分虚拟焦点小组（n = 3）和第3部分虚拟个人访谈（n = 8）中，参与者共同倾向于通过以下方式增强应用：（1）自动添加用药数据以进行跟踪的能力，以及（2）就其自我报告的健康体验接收相关护理团队反馈的能力。参与者愿意每天花10 - 15分钟跟踪4 - 5次健康体验，特别是那些医疗服务提供者要求的体验。
参与者更喜欢能够减轻用户负担并提供与其相关信息的应用。“今日关爱连接”可以通过自动添加用药数据以进行跟踪以及在应用中提供护理团队对患者自我报告健康体验的反馈，为CAD、PAD患者或两者兼有的患者优化用户体验。
